DexCom Inc (DXCM) stock
DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3030% below fair value
$83.33+1.94 (+2.38%)
Close on Nov 13, 2026Market cap $31.08BP/E 32.8Yield –
DexCom gross margin
Gross margin is gross profit as a percentage of revenue.
DexCom's gross margin for the twelve months ending Sep 30, 2026 was 63.4%. For fiscal 2025 it was 60.1%, against 60.5% the year before. The highest annual figure on record is 69.3% in fiscal 2015.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 60.1% | −0.4 |
| FY2024 | Dec 31, 2024 | 60.5% | −2.7 |
| FY2023 | Dec 31, 2023 | 63.2% | −1.5 |
| FY2022 | Dec 31, 2022 | 64.7% | −3.9 |
| FY2021 | Dec 31, 2021 | 68.6% | +2.2 |
| FY2020 | Dec 31, 2020 | 66.4% | +3.3 |
| FY2019 | Dec 31, 2019 | 63.1% | −1.2 |
| FY2018 | Dec 31, 2018 | 64.4% | −4.1 |
| FY2017 | Dec 31, 2017 | 68.5% | +2.5 |
| FY2016 | Dec 31, 2016 | 66.0% | −3.2 |
| FY2015 | Dec 31, 2015 | 69.3% | +1.2 |
| FY2014 | Dec 31, 2014 | 68.0% | +5.5 |
| FY2013 | Dec 31, 2013 | 62.6% | +15.9 |
| FY2012 | Dec 31, 2012 | 46.6% | −0.4 |
| FY2011 | Dec 31, 2011 | 47.1% | +9.2 |
| FY2010 | Dec 31, 2010 | 37.9% | +25.5 |
| FY2009 | Dec 31, 2009 | 12.3% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 64.3% | +3.8 |
| Q2 FY2026 | Jun 30, 2026 | 63.4% | +3.9 |
| Q1 FY2026 | Mar 31, 2026 | 62.9% | +6.1 |
| Q4 FY2025 | Dec 31, 2025 | 62.9% | +4.0 |
| Q3 FY2025 | Sep 30, 2025 | 60.5% | +0.8 |
| Q2 FY2025 | Jun 30, 2025 | 59.5% | −2.9 |
| Q1 FY2025 | Mar 31, 2025 | 56.9% | −4.2 |
| Q4 FY2024 | Dec 31, 2024 | 58.9% | −4.6 |
| Q3 FY2024 | Sep 30, 2024 | 59.7% | −4.2 |
| Q2 FY2024 | Jun 30, 2024 | 62.4% | −0.3 |
| Q1 FY2024 | Mar 31, 2024 | 61.0% | −1.4 |
| Q4 FY2023 | Dec 31, 2023 | 63.5% | −2.9 |
| Q3 FY2023 | Sep 30, 2023 | 63.9% | −0.3 |
| Q2 FY2023 | Jun 30, 2023 | 62.7% | −1.9 |
| Q1 FY2023 | Mar 31, 2023 | 62.4% | −0.9 |
| Q4 FY2022 | Dec 31, 2022 | 66.4% | −1.3 |
| Q3 FY2022 | Sep 30, 2022 | 64.2% | −4.5 |
| Q2 FY2022 | Jun 30, 2022 | 64.6% | −5.5 |
| Q1 FY2022 | Mar 31, 2022 | 63.3% | −4.8 |
| Q4 FY2021 | Dec 31, 2021 | 67.7% | −2.5 |
| Q3 FY2021 | Sep 30, 2021 | 68.7% | +0.8 |
| Q2 FY2021 | Jun 30, 2021 | 70.1% | +7.2 |
| Q1 FY2021 | Mar 31, 2021 | 68.1% | +4.8 |
| Q4 FY2020 | Dec 31, 2020 | 70.2% | +3.3 |
| Q3 FY2020 | Sep 30, 2020 | 68.0% | +5.7 |
| Q2 FY2020 | Jun 30, 2020 | 62.9% | +1.5 |
| Q1 FY2020 | Mar 31, 2020 | 63.3% | +3.1 |
| Q4 FY2019 | Dec 31, 2019 | 66.8% | +0.9 |
| Q3 FY2019 | Sep 30, 2019 | 62.3% | −0.9 |
| Q2 FY2019 | Jun 30, 2019 | 61.4% | −2.0 |
| Q1 FY2019 | Mar 31, 2019 | 60.2% | −4.3 |
| Q4 FY2018 | Dec 31, 2018 | 65.9% | −3.5 |
| Q3 FY2018 | Sep 30, 2018 | 63.2% | −5.6 |
| Q2 FY2018 | Jun 30, 2018 | 63.3% | −5.5 |
| Q1 FY2018 | Mar 31, 2018 | 64.5% | −1.6 |
| Q4 FY2017 | Dec 31, 2017 | 69.5% | +1.3 |
| Q3 FY2017 | Sep 30, 2017 | 68.8% | – |
| Q2 FY2017 | Jun 30, 2017 | 68.9% | – |
| Q1 FY2017 | Mar 31, 2017 | 66.1% | – |
| Q4 FY2016 | Dec 31, 2016 | 68.2% | – |
See a number that looks wrong?